Clinical Trial Update: p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial tests the safety of the p28 peptide in younger patients with recurrent or progressive central nervous system tumors and the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Atypical Teratoid Rhabdoid Tumor
• Brainstem Glioma
• Choroid Plexus Neoplasms
• Glioblastoma
• Gliosarcoma
• Medulloblastoma

Drugs mentioned

• p28 (p28)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Teratoid Tumor, Atypical, Choroid Plexus Neoplasms | Phase 1 | Status: COMPLETED